108 related articles for article (PubMed ID: 6526518)
1. Preparation of a 211At-IgG conjugate which is stable in vivo.
Harrison A; Royle L
Int J Appl Radiat Isot; 1984 Nov; 35(11):1005-8. PubMed ID: 6526518
[TBL] [Abstract][Full Text] [Related]
2. Astatination of proteins using an N-succinimidyl tri-n-butylstannyl benzoate intermediate.
Zalutsky MR; Narula AS
Int J Rad Appl Instrum A; 1988; 39(3):227-32. PubMed ID: 2836342
[TBL] [Abstract][Full Text] [Related]
3. 211At- and 131I-labeled bisphosphonates with high in vivo stability and bone accumulation.
Larsen RH; Murud KM; Akabani G; Hoff P; Bruland OS; Zalutsky MR
J Nucl Med; 1999 Jul; 40(7):1197-203. PubMed ID: 10405142
[TBL] [Abstract][Full Text] [Related]
4. Astatine-211 labeling of internalizing anti-EGFRvIII monoclonal antibody using N-succinimidyl 5-[211At]astato-3-pyridinecarboxylate.
Reist CJ; Foulon CF; Alston K; Bigner DD; Zalutsky MR
Nucl Med Biol; 1999 May; 26(4):405-11. PubMed ID: 10382844
[TBL] [Abstract][Full Text] [Related]
5. Reagents for astatination of biomolecules. 2. Conjugation of anionic boron cage pendant groups to a protein provides a method for direct labeling that is stable to in vivo deastatination.
Wilbur DS; Chyan MK; Hamlin DK; Vessella RL; Wedge TJ; Hawthorne MF
Bioconjug Chem; 2007; 18(4):1226-40. PubMed ID: 17583925
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of astatine-211-labeled monoclonal antibody in treatment of murine T-cell lymphoma.
Harrison A; Royle L
NCI Monogr; 1987; (3):157-8. PubMed ID: 3493441
[TBL] [Abstract][Full Text] [Related]
7. Comparative tissue distribution in mice of the alpha-emitter 211At and 131I as labels of a monoclonal antibody and F(ab')2 fragment.
Garg PK; Harrison CL; Zalutsky MR
Cancer Res; 1990 Jun; 50(12):3514-20. PubMed ID: 2340501
[TBL] [Abstract][Full Text] [Related]
8. Astatine-211 labeling of an antimelanoma antibody and its Fab fragment using N-succinimidyl p-astatobenzoate: comparisons in vivo with the p-[125I]iodobenzoyl conjugate.
Hadley SW; Wilbur DS; Gray MA; Atcher RW
Bioconjug Chem; 1991; 2(3):171-9. PubMed ID: 1932216
[TBL] [Abstract][Full Text] [Related]
9. Preparation and in vivo evaluation of linkers for 211At labeling of humanized anti-Tac.
Yordanov AT; Garmestani K; Zhang M; Zhang Z; Yao Z; Phillips KE; Herring B; Horak E; Beitzel MP; Schwarz UP; Gansow OA; Plascjak PS; Eckelman WC; Waldmann TA; Brechbiel MW
Nucl Med Biol; 2001 Oct; 28(7):845-56. PubMed ID: 11578907
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity of alpha-particle-emitting 5-[211At]astato-2'-deoxyuridine in human cancer cells.
Larsen RH; Vaidyanathan G; Zalutsky MR
Int J Radiat Biol; 1997 Jul; 72(1):79-90. PubMed ID: 9246197
[TBL] [Abstract][Full Text] [Related]
11. The development of a [211At]-astatinated endoradiotherapeutic drug: Part II. Therapeutic results for transplanted adenocarcinoma of the rectum in mice and associated studies.
Brown I; Mitchell JS
Int J Radiat Oncol Biol Phys; 1994 Apr; 29(1):115-24. PubMed ID: 8175418
[TBL] [Abstract][Full Text] [Related]
12. Biodistribution of 6-[211At]astato-2-methyl-1,4-naphthoquinol bis(diphosphate salt) and 211At- in mice with a transplanted rectal adenocarcinoma.
Brown I; Carpenter RN; Mitchell JS
Int J Appl Radiat Isot; 1984 Sep; 35(9):843-7. PubMed ID: 6480147
[TBL] [Abstract][Full Text] [Related]
13. Radiotoxicity of systemically administered 211At-labeled human/mouse chimeric monoclonal antibody: a long-term survival study with histologic analysis.
McLendon RE; Archer GE; Larsen RH; Akabani G; Bigner DD; Zalutsky MR
Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):491-9. PubMed ID: 10487576
[TBL] [Abstract][Full Text] [Related]
14. Astatine-211-labeled biotin conjugates resistant to biotinidase for use in pretargeted radioimmunotherapy.
Foulon CF; Alston KL; Zalutsky MR
Nucl Med Biol; 1998 Feb; 25(2):81-8. PubMed ID: 9468020
[TBL] [Abstract][Full Text] [Related]
15. The development of a [211AT]-astatinated endoradiotherapeutic drug: part IV--late radiation effects.
Brown I; Mitchell JS
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1177-83. PubMed ID: 9539575
[TBL] [Abstract][Full Text] [Related]
16. Labeling monoclonal antibodies and F(ab')2 fragments with the alpha-particle-emitting nuclide astatine-211: preservation of immunoreactivity and in vivo localizing capacity.
Zalutsky MR; Garg PK; Friedman HS; Bigner DD
Proc Natl Acad Sci U S A; 1989 Sep; 86(18):7149-53. PubMed ID: 2476813
[TBL] [Abstract][Full Text] [Related]
17. Streptavidin in antibody pretargeting. 5. chemical modification of recombinant streptavidin for labeling with the alpha-particle-emitting radionuclides 213Bi and 211At.
Wilbur DS; Hamlin DK; Chyan MK; Brechbiel MW
Bioconjug Chem; 2008 Jan; 19(1):158-70. PubMed ID: 18072725
[TBL] [Abstract][Full Text] [Related]
18. Preparation of 211At-labeled humanized anti-Tac using 211At produced in disposable internal and external bismuth targets.
Schwarz UP; Plascjak P; Beitzel MP; Gansow OA; Eckelman WC; Waldmann TA
Nucl Med Biol; 1998 Feb; 25(2):89-93. PubMed ID: 9468021
[TBL] [Abstract][Full Text] [Related]
19. N-succinimidyl 3-[211At]astato-4-guanidinomethylbenzoate: an acylation agent for labeling internalizing antibodies with alpha-particle emitting 211At.
Vaidyanathan G; Affleck DJ; Bigner DD; Zalutsky MR
Nucl Med Biol; 2003 May; 30(4):351-9. PubMed ID: 12767391
[TBL] [Abstract][Full Text] [Related]
20. Alpha-particle radiotherapy with 211At-labeled monodisperse polymer particles, 211At-labeled IgG proteins, and free 211At in a murine intraperitoneal tumor model.
Larsen RH; Hoff P; Vergote IB; Bruland OS; Aas M; De Vos L; Nustad K
Gynecol Oncol; 1995 Apr; 57(1):9-15. PubMed ID: 7705707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
